Wave Life Sciences (WVE) Profit After Tax (2014 - 2026)
Wave Life Sciences (WVE) posted Profit After Tax of -$26.1 million for Q1 2026, up 50.93% on a QoQ basis from -$53.2 million in Q4 2025, and up 44.35% year-over-year from -$18.1 million in Q1 2025.
Wave Life Sciences (WVE) Profit After Tax (2014 - 2026) Analysis & Trends
Wave Life Sciences' Profit After Tax history runs 13 years deep, the most recent figure standing at -$26.1 million for Q1 2026.
- Quarterly Profit After Tax rose 44.35% year-over-year to -$26.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$183.6 million (down 63.23% YoY) and the FY2025 annual result came in at -$204.4 million, down 110.37% from the prior year.
- Profit After Tax was -$26.1 million for Q1 2026 at Wave Life Sciences, up from -$53.2 million in the prior quarter.
- Across five years, Profit After Tax topped out at $29.1 million in Q4 2024 and bottomed at -$61.8 million in Q3 2024.
- A 5-year average of -$32.2 million and a median of -$37.8 million in 2022 frame the typical range for Profit After Tax.
- Peak annual rise in Profit After Tax reached 280.8% in 2024, while the deepest fall reached 955.68% in 2024.
- Wave Life Sciences' Profit After Tax stood at -$43.6 million in 2022, then jumped by 63.08% to -$16.1 million in 2023, then soared by 280.8% to $29.1 million in 2024, then tumbled by 282.61% to -$53.2 million in 2025, then soared by 50.93% to -$26.1 million in 2026.
- Business Quant data shows WVE's Profit After Tax at -$26.1 million in Q1 2026, -$53.2 million in Q4 2025, and -$53.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -36.84 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 227.36 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.03 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -65.60 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | -26.94 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 362.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -453.82 Mn |
| 10 | Wave Life Sciences | 1.16 Bn | 612.38 Mn | - | -26.09 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -26.09 Mn |
| Dec 31, 2025 | -53.17 Mn |
| Sep 30, 2025 | -53.85 Mn |
| Jun 30, 2025 | -50.47 Mn |
| Mar 31, 2025 | -46.88 Mn |
| Dec 31, 2024 | 29.12 Mn |
| Sep 30, 2024 | -61.78 Mn |
| Jun 30, 2024 | -32.92 Mn |
| Mar 31, 2024 | -31.56 Mn |
| Dec 31, 2023 | -16.10 Mn |
| Sep 30, 2023 | 7.22 Mn |
| Jun 30, 2023 | -21.10 Mn |
| Mar 31, 2023 | -27.41 Mn |
| Dec 31, 2022 | -43.62 Mn |
| Sep 30, 2022 | -39.00 Mn |
| Jun 30, 2022 | -41.30 Mn |
| Mar 31, 2022 | -37.81 Mn |
| Dec 31, 2021 | -34.99 Mn |
| Sep 30, 2021 | -6.24 Mn |
| Jun 30, 2021 | -38.77 Mn |